85 related articles for article (PubMed ID: 30551474)
1. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
[TBL] [Abstract][Full Text] [Related]
4. Decreased NMIIA heavy chain phosphorylation at S1943 promotes mitoxantrone resistance by upregulating BCRP and N-cadherin expression in breast cancer cells.
Li K; Li T; Niu Y; Gao Y; Shi Y; He Y; Zhang X; Wang Y; Cao J; Hu X; Chen M; Shi R
Biochem Cell Biol; 2024 Jun; 102(3):213-225. PubMed ID: 38190650
[TBL] [Abstract][Full Text] [Related]
5. Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner.
Huttunen J; Tampio J; Järvinen J; Montaser AB; Markowicz-Piasecka M; Huttunen KM
Chem Biol Interact; 2024 Jan; 388():110833. PubMed ID: 38101600
[TBL] [Abstract][Full Text] [Related]
6. The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy.
Theodossiou TA; Olsen CE; Jonsson M; Kubin A; Hothersall JS; Berg K
Redox Biol; 2017 Aug; 12():191-197. PubMed ID: 28254657
[TBL] [Abstract][Full Text] [Related]
7. Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Majerník M; Jendželovský R; Babinčák M; Košuth J; Ševc J; Tonelli Gombalová Z; Jendželovská Z; Buríková M; Fedoročko P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248208
[TBL] [Abstract][Full Text] [Related]
8. The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue.
Weidner LD; Kannan P; Mitsios N; Kang SJ; Hall MD; Theodore WH; Innis RB; Mulder J
Epilepsia; 2018 Aug; 59(8):1507-1517. PubMed ID: 30030837
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells.
Chen XY; Wu ZX; Wang JQ; Teng QX; Tang H; Liu Q; Chen ZS; Chen W
Front Pharmacol; 2024; 15():1400699. PubMed ID: 38756373
[TBL] [Abstract][Full Text] [Related]
10. Hypericin supramolecular assembles: A way to increase the skin availability and photodynamic efficiency in tumor cells.
Gusmão LA; Rodero CF; Pironi AM; Chorilli M; Perussi JR
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103858. PubMed ID: 37898262
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of disodium cromoglicate as a novel effective hydrotrope solvent for hypericin utilisation in photodynamic therapy.
Suváková M; Majerník M; Jendželovský R; Hovan A; Bánó G; Fedoročko P; Antalík M
J Photochem Photobiol B; 2020 Mar; 206():111855. PubMed ID: 32220773
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory Effect of Hypericin-Mediated Photodynamic Therapy on Oral Cancer Cells.
Olek M; Machorowska-Pieniążek A; Czuba ZP; Cieślar G; Kawczyk-Krupka A
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258051
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Multidrug Resistance Gene Expression by Coumarin Derivatives in Human Leukemic Cells.
Kubrak T; Bogucka-Kocka A; Komsta Ł; Załuski D; Bogucki J; Galkowski D; Kaczmarczyk R; Feldo M; Cioch M; Kocki J
Oxid Med Cell Longev; 2017; 2017():5647281. PubMed ID: 29387293
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Antifungal Treatment of
Sato MR; Oshiro-Junior JA; Rodero CF; Boni FI; Araújo VHS; Bauab TM; Nicholas D; Callan JF; Chorilli M
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631009
[TBL] [Abstract][Full Text] [Related]
15. Advanced theranostic nanoplatforms for hypericin delivery in the cancer treatment.
de Morais FAP; Balbinot RB; Bakoshi ABK; Lazarin-Bidoia D; da Silva Souza Campanholi K; da Silva Junior RC; Gonçalves RS; Ueda-Nakamura T; de Oliveira Silva S; Caetano W; Nakamura CV
J Photochem Photobiol B; 2023 Oct; 247():112782. PubMed ID: 37660488
[TBL] [Abstract][Full Text] [Related]
16. ATP Mimetic Attack on the Nucleotide-Binding Domain to Overcome ABC Transporter Mediated Chemoresistance.
Grigoreva TA; Sagaidak AV; Vorona SV; Novikova DS; Tribulovich VG
ACS Med Chem Lett; 2022 Dec; 13(12):1848-1855. PubMed ID: 36518704
[TBL] [Abstract][Full Text] [Related]
17. The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancers.
King A; Maisey T; Harris EL; Poulter JA; Jayne DG; Khot MI
Photochem Photobiol Sci; 2024 Jun; 23(6):1067-1075. PubMed ID: 38625651
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.
Cao J; Zhang Z; Zhou L; Luo M; Li L; Li B; Nice EC; He W; Zheng S; Huang C
MedComm (2020); 2023 Dec; 4(6):e427. PubMed ID: 38045829
[TBL] [Abstract][Full Text] [Related]
19. IL-1β functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-ĸB activation.
Lu X; Chen M; Shen J; Xu Y; Wu H
Cell Biol Int; 2019 Mar; 43(3):279-289. PubMed ID: 30632646
[TBL] [Abstract][Full Text] [Related]
20. Hypericin-mediated photodynamic therapy for the treatment of cancer: a review.
Dong X; Zeng Y; Zhang Z; Fu J; You L; He Y; Hao Y; Gu Z; Yu Z; Qu C; Yin X; Ni J; Cruz LJ
J Pharm Pharmacol; 2021 Mar; 73(4):425-436. PubMed ID: 33793828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
